Imagion Biosystems reports positive results from Wayne State collaboration as Phase 2 breast cancer trial advances

Clinical-stage imaging company Imagion Biosystems (ASX:IBX) has reported encouraging new data from its collaboration with Wayne State University, supporting plans to progress its proprietary MagSense HER2 imaging agent toward a Phase 2 clinical trial in patients with HER2-positive breast cancer. …